Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Optom Vis Sci. 2012 Oct;89(10):1512–1520. doi: 10.1097/OPX.0b013e318269c8f9

Table 1.

Convergence Insufficiency Symptom Survey overall score* and mean subscale score** for performance- and eye-related items prior to treatment.

Patient Characteristic n Overall score:
mean (SD)
Performance-
related subscale
score: mean (SD)
Eye-related
subscale score:
mean (SD)
Sex
   Female 131 30.3 (9.2) 2.3 (0.7) 1.8 (0.8)
   Male 90 29.2 (8.6) 2.3 (0.8) 1.7 (0.5)
p-value (t-test) 0.40 0.58 0.44

Age
   9–10 years 76 28.7 (7.8) 2.3 (0.7) 1.7 (0.7)
   11–12 years 69 29.4 (8.6) 2.3 (0.8) 1.8 (0.7)
   13–14 years 39 31.2 (10.7) 2.4 (1.0) 1.9 (0.8)
   15–17 years 37 31.7 (9.3) 2.3 (0.7) 2.0 (0.8)
p-value (regression) 0.048 0.48 0.022

Race/ethnicity
   African American 59 30.5 (8.7) 2.4 (0.7) 1.8 (0.7)
   Hispanic 75 29.4 (9.9) 2.3 (0.8) 1.7 (0.8)
   White 78 30.4 (8.1) 2.3 (0.7) 1.9 (0.7)
p-value (ANOVA) 0.69 0.91 0.56

Parent-reported ADHD status††
   No ADHD 178 29.5 (8.7) 2.2 (0.8) 1.8 (0.7)
   ADHD 34 34.1 (8.6) 2.8 (0.5) 1.9 (0.8)
p-value (t-test) 0.005 <0.0001 0.31

Sum of item responses (range: 0–60)

**

Average level of all items (range: 0–4)

n=212 (9 subjects categorized as “other” excluded from analysis)

††

n=212 (Missing ADHD status for 9 children)